BioPatrika

@biopatrika.bsky.social

Science News | Biotech | #Scicomm | #interview | #scikonnect | #career | #Mentors | #Jobs | #biopatrika | Managed by SciKonnect @Singh_Virender

#researcherspotlight Kanika Rawat from Dr. Kavita Isvaran lab at Indian Institute of Science (IISc) Bangalore talks about her work on "How Group Living Shapes Predator Responses in Aedes aegypti Mosquitoes" Royal Society Publishing #mosquito biopatrika.com/academia/res... via @biopatrika

How Group Living Shapes Predator Responses in Aedes aegypti Mosquitoes | BioPatrika

Group living can mask the effects of early-life predation risk, altering behavioural responses in Aedes aegypti mosquito pupae.

biopatrika.com

#researcherspotlight Priya Chouhan from Dr. Amit Tuli lab at CSIR Institute Of Microbial Technology and Yogita Phogat from Dr. Mahak Sharma lab at IISER Mohali talks about their work on "Tracking the journey of LAMP1 to lysosome directed by Arl8b" #JCellBiol biopatrika.com/academia/res...

Tracking the journey of LAMP1 to lysosome directed by Arl8b | BioPatrika

How Arl8b regulates LAMP1 delivery to lysosomes by blocking Rab11a recycling, ensuring proper lysosome biogenesis and function.

biopatrika.com

Huge thanks to @biopatrika.bsky.social for featuring our work through #researcherspotlight 😊 We talked about the “why” behind the science, the lab’s aha moments, and what lies ahead. 👩🏻‍🔬

BioPatrika@biopatrika.bsky.social · 6mo ago

#researcherspotlight Dr. Navneet Shahi @navneetshahi.bsky.social from Prof, Kavita Babu lab @kavita-babu.bsky.social at IISc Bangalore talks about her work on "How a Single Neuron Controls Social Swarming in Worms" #CNSIISc biopatrika.com/academia/res... via @biopatrika.bsky.social

🚨 Big news in oncology! Bicara Therapeutics’ ficerafusp alfa earns FDA Breakthrough Therapy Designation for first-line treatment of HPV-negative recurrent/metastatic head & neck cancer — a tough-to-treat form with limited options. #cancer #FDA #oncology 🔗 Read more: biopatrika.com/industry/pha...

Bicara Therapeutics Receives FDA Breakthrough Therapy status for cancer drug - BioPatrika

Pharma & Biopharma - Bicara Therapeutics Receives FDA Breakthrough Therapy Designation for Ficerafusp Alfa in HPV-Negative Head and Neck Cancer

biopatrika.com